NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MicrobiotiX Co.,LTD

MicrobiotiX Co.,LTD

Private
SeoulHealthcare & Life Scienceshttps://microbiotix.net/

Last Round

Series B

Aug 29, 2025

Total Funding Raised

$32.58M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

MicrobiotiX Co.,LTD is a biotechnology company that specializes in the advancement of cutting-edge bacteriophage-based therapeutics to address multidrug-resistant pathogens.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Revenue Share

AI Layer

Application

Keywords

bacteriophage therapyphage therapyantimicrobial resistanceAMRmultidrug-resistant infectionMDRcontract manufacturing organizationCMOCDMOdrug discoveryAI drug discoverybiotechnologyclinical trialscGMP manufacturingprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MicrobiotiX Co.,LTD Comps

Public and private peers based on sector, stage, and business model.

MicrobiotiX Co.,LTD comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MicrobiotiX Co.,LTD Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 29, 2025
GrantAug 29, 2025
Series BOct 21, 2024
VC RoundMar 30, 2022
Series ASep 28, 2021

Key People

Founding team and executive leadership

Dongeun Yong

Chief Executive Officer, Chief Scientific Officer

Executive Team

MicrobiotiX Co.,LTD Investors

Notable investors and investment history

MicrobiotiX Co.,LTD investors
InvestorRounds
DSC InvestmentVC Round, Series A, Series B
Korea Investment PartnersSeries B
Paratus InvestmentSeries B
Otium CapitalSeries B
Wanted LabSeries B
S&S InvestmentSeries B
Premier PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 29, 2025

    $14.3M round closed.

MicrobiotiX Co.,LTD Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MicrobiotiX Co.,LTD Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MicrobiotiX Co.,LTD's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range7
Year Founded2016
Last FundingAug 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.